Menu Search
Equities

Bluechiip Ltd

1BL:FRA

Bluechiip Ltd

Actions
  • Price (EUR)0.001
  • Today's Change0.00 / 0.00%
  • Shares traded20.00k
  • 1 Year change-89.45%
  • Beta--
Data delayed at least 15 minutes, as of Sep 30 2024 08:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bluechiip Limited is an Australia-based company, which is engaged in the development of advanced sample management solutions for harsh environments. The principal activity of the Company is the development and commercialization of a wireless tracking solution for the healthcare and life science, security, defense, and manufacturing industries. Its solutions include Bluechiip Enabled Solutions, Custom Solutions and Partnerships. The Company offers a range of services across product design, engineering and manufacturing. It also offers partners the ability to license its patented technology to differentiate their product and service offerings. The Company's Sample Storage solutions include Bluechiip Enabled CryoVial Range, Bluechiip Enabled CryoBoxes, Bluechiip Enabled CryoTags and a range of accessories for all advanced sample management needs. Its Readers solutions include Bluechiip Enabled Handheld Reader, Bluechiip Enabled Multivial Reader and Bluechiip Enabled CryoBox Tracker.

  • Revenue in AUD (TTM)484.69k
  • Net income in AUD-5.81m
  • Incorporated2003
  • Employees7.00
  • Location
    Bluechiip Ltd1 Dalmore Drive scoresbyMELBOURNE 3179AustraliaAUS
  • Phone+61 39763-9763
  • Fax+61 39763-9764
  • Websitehttps://www.bluechiip.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.